SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1od5'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GTI_F_CCSF47_0
(GLUTATHIONE
S-TRANSFERASE)		 1od5 GLYCININ
(Glycine
max) 		4 / 5 THR A 239
LEU A 244
GLY A 243
TYR A 134
 None
 1.36A 1gtiF-1od5A:
0.0		 1gtiF-1od5A:
18.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MXD_A_ACRA733_1
(ALPHA AMYLASE)		 1od5 GLYCININ
(Glycine
max) 		4 / 6 SER A 150
ASN A 154
LEU A 156
ASP A 157
 None
 1.33A 1mxdA-1od5A:
3.7		 1mxdA-1od5A:
22.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2AYL_A_FLPA1701_1
(PROSTAGLANDIN G/H
SYNTHASE 1)		 1od5 GLYCININ
(Glycine
max) 		6 / 12 VAL A  47
LEU A 146
LEU A 421
GLY A  44
ALA A  43
LEU A  40
 None
 1.48A 2aylA-1od5A:
0.0		 2aylA-1od5A:
21.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2H42_B_VIAB902_1
(CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE)		 1od5 GLYCININ
(Glycine
max) 		5 / 12 ALA A 336
ILE A 335
VAL A  72
ALA A 143
ILE A  69
 None
None
None
CO3  A 496 ( 4.6A)
None
 1.11A 2h42B-1od5A:
undetectable		 2h42B-1od5A:
19.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JAY_A_SAMA1101_0
(STRUCTURAL PROTEIN
VP3)		 1od5 GLYCININ
(Glycine
max) 		5 / 12 MET A  68
GLU A 333
ARG A 350
VAL A 372
GLU A 440
 None
 1.42A 3jayA-1od5A:
0.3		 3jayA-1od5A:
18.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KK6_A_CELA701_1
(PROSTAGLANDIN G/H
SYNTHASE 1)		 1od5 GLYCININ
(Glycine
max) 		5 / 12 LEU A 146
LEU A 421
SER A 368
GLY A  44
ALA A  43
 None
 1.11A 3kk6A-1od5A:
0.0		 3kk6A-1od5A:
21.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A7B_B_HAEB1270_1
(COLLAGENASE 3)		 1od5 GLYCININ
(Glycine
max) 		4 / 5 LEU A  40
HIS A  37
HIS A 173
GLU A 175
 None
 1.31A 4a7bB-1od5A:
undetectable		 4a7bB-1od5A:
14.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A84_A_DXCA1160_0
(MAJOR POLLEN
ALLERGEN BET V 1-A)		 1od5 GLYCININ
(Glycine
max) 		5 / 12 VAL A 403
ILE A 392
VAL A 372
ILE A 351
SER A 452
 None
 1.26A 4a84A-1od5A:
undetectable		 4a84A-1od5A:
16.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4TWD_C_377C401_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 1od5 GLYCININ
(Glycine
max) 		4 / 6 TYR A 131
GLU A 172
TYR A 164
LEU A  59
 CO3  A 496 (-4.4A)
None
None
None
 1.19A 4twdB-1od5A:
undetectable
4twdC-1od5A:
undetectable		 4twdB-1od5A:
19.68
4twdC-1od5A:
19.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4TWD_E_377E401_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 1od5 GLYCININ
(Glycine
max) 		4 / 6 TYR A 131
GLU A 172
TYR A 164
LEU A  59
 CO3  A 496 (-4.4A)
None
None
None
 1.11A 4twdD-1od5A:
0.0
4twdE-1od5A:
undetectable		 4twdD-1od5A:
19.68
4twdE-1od5A:
19.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4TWD_G_377G401_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 1od5 GLYCININ
(Glycine
max) 		4 / 6 TYR A 131
GLU A 172
TYR A 164
LEU A  59
 CO3  A 496 (-4.4A)
None
None
None
 1.21A 4twdF-1od5A:
0.0
4twdG-1od5A:
0.0		 4twdF-1od5A:
19.68
4twdG-1od5A:
19.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4TWD_J_377J401_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 1od5 GLYCININ
(Glycine
max) 		4 / 6 TYR A 131
GLU A 172
TYR A 164
LEU A  59
 CO3  A 496 (-4.4A)
None
None
None
 1.22A 4twdI-1od5A:
0.0
4twdJ-1od5A:
0.0		 4twdI-1od5A:
19.68
4twdJ-1od5A:
19.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EML_A_SAMA701_0
(PROTEIN ARGININE
N-METHYLTRANSFERASE
5)		 1od5 GLYCININ
(Glycine
max) 		5 / 12 PRO A 489
GLY A 378
LEU A 439
ASN A 345
GLU A 432
 None
 1.41A 5emlA-1od5A:
undetectable		 5emlA-1od5A:
21.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5WYQ_B_SAMB301_0
(TRNA
(GUANINE-N(1)-)-METH
YLTRANSFERASE)		 1od5 GLYCININ
(Glycine
max) 		5 / 12 LEU A 374
GLY A 438
ILE A 379
GLY A 435
GLY A 434
 None
 1.00A 5wyqB-1od5A:
undetectable		 5wyqB-1od5A:
17.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X80_A_SALA201_1
(UNCHARACTERIZED
HTH-TYPE
TRANSCRIPTIONAL
REGULATOR RV2887)		 1od5 GLYCININ
(Glycine
max) 		4 / 5 VAL A 204
PRO A 169
GLY A 167
TYR A 164
 None
 1.19A 5x80A-1od5A:
0.0
5x80B-1od5A:
0.0		 5x80A-1od5A:
13.62
5x80B-1od5A:
13.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X80_D_SALD201_1
(UNCHARACTERIZED
HTH-TYPE
TRANSCRIPTIONAL
REGULATOR RV2887)		 1od5 GLYCININ
(Glycine
max) 		4 / 5 PRO A 169
GLY A 167
TYR A 164
VAL A 204
 None
 1.24A 5x80C-1od5A:
0.0
5x80D-1od5A:
0.0		 5x80C-1od5A:
13.62
5x80D-1od5A:
13.62